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Copper (Cu) is an essential transition metal ion required as cofactor in many key enzymes. After cell
uptake of Cu, the metal is transported by the cytoplasmic Cu chaperone Atox1 to P1B-type ATPases in the
Golgi network for incorporation into Cu-dependent enzymes in the secretory path. Cu is vital for many
steps of cancer progression and Atox1 was recently suggested to have additional functionality as a nu-
clear transcription factor. We here investigated the expression level, cellular localization and role in cell
migration of Atox1 in an aggressive breast cancer cell line upon combining immunostaining, microscopy
and a wound healing assay. We made the unexpected discovery that Atox1 accumulates at lamellipodia
borders of migrating cancer cells and Atox1 silencing resulted in migration defects as evidenced from
reduced wound closure. Therefore, we have discovered an unknown role of the Cu chaperone Atox1 in
breast cancer cell migration.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Copper (Cu) is found in the active sites of proteins that participate
in cellular reactions such as respiration, antioxidant defense,
neurotransmitter biosynthesis, connective-tissue biosynthesis and
pigment formation [1e3]. To avoid toxicity of Cu, the intracellular
concentration of Cu is regulated via dedicated proteins that facilitate
its uptake, efﬂux as well as distribution to target Cu-dependent
proteins and enzymes [4e6]. In humans, the 68-residue Cu chap-
erone Atox1 [7] picks up Cu that has entered the cell via the
membrane-bound Cu importer Ctr1 and delivers the metal to
cytoplasmic metal-binding domains in ATP7A and ATP7B, two ho-
mologousmulti-domain P1B-typeATPases located in the trans-Golgi
network. Many human Cu-dependent enzymes acquire Cu in the
Golgi before reaching their ﬁnal destination [4e6]. Intriguingly,
Atox1was recently reported tohave additional functionality as a Cu-
dependent transcription factor (TF) promoting the expression of
Ccd1 (cyclin D1) [8], SOD3 [9,10] and NADPH oxidase [11].
Since Cu is a key component of many essential enzymes [12e14],
it is not surprising that Cu is required for at least three characteristic
phenomena involved in cancer: proliferative immortality, angio-
genesis and metastasis. Roles in cancer metastasis of the Cu-
dependent proteins LOX [15], SPARC [16], Mek1 [17] and MEMO; Ccd1, cyclin D1.
ittung-Stafshede).
Inc. This is an open access article u[18] have been reported. Cancer metastasis consists of a cascade of
processes that depends sensitively on cell migration ability. Upon
local tissue invasion, cancer cells migrate through the tumor stroma
and blood vessels to reach and grow at distant metastatic sites [19].
This requires cells to adopt to, interact with, and modify their
surrounding extracellular matrix. Local cell invasion and migration
are achieved by the formation of actin-rich plasma membrane
protrusions at the leading edge known as lamellipodia, ﬁlopodia,
and invadopodia. Intriguingly, in models of angiogenesis and neu-
rogenesis, 80e90% of the total Cu stores in intracellular compart-
ments was reported to be re-located to ﬁlopodia protrusions and
across the cell membrane of endothelial cells [20]. The accumulated
Cu in and outside the ﬁlopodia protrusions was proposed to be
protein-bound but no target protein was identiﬁed. Despite the
apparent importance for Cu and Cu-dependent enzymes in cancer
processes, the roles of Cu transport proteins, such as Atox1, are
unknown. To assess the putative role of Atox1 in breast cancer
progression, we here used aggressive MDA-MB-231 breast cancer
cells to investigate the functional role of Atox1 in cell migration.2. Materials and methods
2.1. Cell lines
MCF7 and MDA-MB-231 human breast cancer cell lines were
obtained from American Type Culture Collection (LGC standards).
Both cell lines were maintained at 37 and 5% CO2 in Eagles MEM
(Sigma-Aldrich), supplemented with 10% heat inactivated fetalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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(Invitrogen).
2.2. Western blot
Proteinswere extracted by lysis buffer containing 50mMTris HCl,
150 mM NaCl, 1 mM EDTA, 1% Triton and 100 mL/mL protease in-
hibitor cocktail (Roche). Protein concentrations were measured by
the colorimetric BCA protein assay reagent (Alfa Aesar). Equal
amounts of protein for each samplewere subjected to SDS/PAGE and
transferred onto PVDFmembranes (Bio-Rad, California).Membranes
were ﬁrst probed with primary antibodies (rabbit monoclonal) anti-
Atox1 antibody (Abcam); rabbit polyclonal anti-beta actin antibodyFig. 1. Atox1 accumulates in the lamellipodium border of MDA-MB-231 cells. (A) Confo
bar ¼ 30 mm).
Fig. 2. Atox1 silencing in MDA-MB-231 cells results in a uniformly-distributed Atox1
Immunoblot and (B) quantiﬁcation of total Atox1 expression in cells transfected with increa
mock versus 50 nM Atox1 siRNA transfected cells. (D) Percentage of lamellipodia-forming ce
2) (nmicrographs¼5; ncells¼350).(Abcam)) and subsequently with HRP-conjugated goat anti-rabbit
secondary antibody (Sigma). Protein bands were detected using the
ECL plus Western blotting detection system (GE Healthcare).
2.3. Immunoﬂuorescence staining
Cells plated on poly-L-lysine coated coverslips were ﬁxed during
20 min incubation with 4% paraformaldehyde, washed with PBS,
and blocked plus permeabilized during 45 min incubationwith 10%
fetal bovine serum plus 0.1% Triton-X-100 in PBS. Samples were
then incubated with mouse monoclonal anti-Atox1 primary anti-
body (Abcam) diluted in 1% blocking buffer overnight at 4. After
washing, samples were incubated with Alexa Fluor 488-conjugatedcal ﬂuorescent image (green ¼ Atox1; blue ¼ DAPI), and (B) bright ﬁeld image. (Scale
downregulation, but no effect on lamellipodia-forming potential of the cells. (A)
sing concentrations of siRNA towards Atox1. (C) Atox1 immunoﬂuorescence staining of
lls in mock and Atox1 siRNA transfected cells 1) (error bar; standard error of the mean);
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blocking buffer for 1 h. Samples were washed with PBS, stained
with DAPI, mounted and analyzed with a LSM700 inverted micro-
scope (Carl Zeiss Jena GmbH, Germany) using a plan-apochromat
40/1.3 oil DIC objective.
2.4. Atox1 silencing
Cells were transfected with FlexiTube siRNAs targeting four
different Atox1 sequences (Qiagen; see Cat.No. 1027416 for sequence
information) using Lipofectamine RNAiMAX transfection reagent
(Invitrogen).
2.5. Wound healing assay
Artiﬁcial wounds were created 24 h after cell seeding in tissue
culture-treated6-well plate using a P-200pipette tip to scratchon the
cell monolayer. Wounds were measured on bright ﬁeldmicrographs.
3. Results
3.1. Atox1 accumulates in the lamellipodium border of breast
cancer cells
We ﬁrst conﬁrmed expression of Atox1 in MCF7 and MDA-MB-
231 breast cancer cell lines. Atox1 immunoﬂuorescence staining
demonstrated that the Atox1 is not only located in the nucleus and
cytoplasm of the cells, but also, surprisingly, at lamellipodia bordersFig. 3. Atox1 downregulation reduces migration of MDA-MB-231 cells. (A) Bright ﬁeld mic
cell monolayers (lines along the border of the wounds). (B)Wound closure measured at 0 h,of both cell lines (Fig. 1).
3.2. Atox1 silencing does not affect the lamellipodia formation by
MDA-MB-231 cells
Because lamellipodia are membrane protrusions that drive cell
migration, we investigated the role of Atox1 in the migration of
MDA-MB-231 cells by evaluation of its morphology (lamellipodia-
formation) and functionality (cell migration) upon Atox1 silencing.
We reached 60% downregulation of Atox1 protein expression in
cells transfected with 100 nM siRNAs against Atox1 (Fig. 2A).
Reduction in Atox1 protein appeared uniformly-distributed in the
cell (Fig. 2B) and did not affect the lamellipodium-formation po-
tential of the cells (Fig. 2C).
3.3. Atox1 downregulated expression reduces the migration of
MDA-MB-231 cells
To probe the role of Atox1 in the motility of the MDA-MB-
231 cells we applied a wound healing assay. We detected a 50%
reduction inwound closure for cells silenced to 60% with respect to
Atox1 expression (Fig. 3). This result suggests that presence of
Atox1 is required for MDA-MB-231 cell migration in vitro.
4. Discussion
Cu and Cu-binding proteins are essential in hallmarks of cancer,
and there is a growing evidence that Cu directly inﬂuences therographs of wounds at 0 h and 24 h after wounding of mock and 100 nM siRNA-treated
24 h and 48 h after wounding (error bar; standard error of the mean) (nmicrographs¼10).
S. Blockhuys, P. Wittung-Stafshede / Biochemical and Biophysical Research Communications 483 (2017) 301e304304ability of cancerous cells to invade and metastasize [15,16,18].
Cancer cell migration is mediated by lamellipodial protrusions and
is a key phenomenon during cancer metastasis. Here, we discov-
ered that the Cu chaperone Atox1 plays an essential role in breast
cancer cell migration in vitro, and it locates to the borders of cellular
lamellipodia of migrating cells. In accord with our ﬁndings, a recent
study reported that Atox1was essential for platelet-derived growth
factor-induced vascular smooth muscle cell migration. It was
demonstrated that the process involved relocation of Atox1 (and
ATP7A) to the leading edge of lamellipodia structures [21]. Thus it
appears that the discovered role of Atox1 in breast cancer cell
migration may be extended to other migrating cell types.
In conclusion, in addition to cytoplasmic Cu transport and nu-
clear transcription factor roles, Atox1 appears to have a new role in
cell migration that entails positioning at the cell border. Lamelli-
podia are powered by actin polymerization, which depends on the
activity of many proteins [22]. Atox1 may provide Cu to Cu-binding
proteins (e.g., MEMO, LOX) activated at the leading edge of
migratory cells. MEMO is a novel Cu-dependent protein found to be
important for cancer cell migration and regulation of actin dy-
namics [18,23] that may be loaded with Cu via Atox1 at the
lamellipodia border. On the other hand, Atox1 may deliver Cu to
LOX via ATP7A at the lamellipodia border, thereby activating LOX
extra-cellular matrix remodeling [21]. Further molecular studies
are needed to elucidate Atox1 interaction partners at the lamelli-
podia border and involved signaling pathways.
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